Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
NCT04245670
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:
- NCT04245670 ↗
- Unknown
- Sunnybrook Health Sciences Centre
- Focused
We haven't built an HCP commentary report on NCT04245670 (prostate cancer; tests no drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT04245670 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:A Phase II Study (5STAR-PC)
- Phase
- Phase not applicable
- Status
- Unknown
- Conditions
- Prostate Cancer
- Interventions
- Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5
- Arms
- Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5 · Experimental
- Enrollment
- 75 (estimated)
- Primary outcomes
- Acute Toxicity
- Acute Toxicity
- Sponsor
- Sunnybrook Health Sciences Centre with Prostate Cure Foundation
- Start
- May 31, 2018
- Primary completion
- Aug 30, 2021
- Results posted
- No
- Registry record
- NCT04245670 · updated Sep 28, 2022